High-Throughput Screening (HTS) revolutionized drug discovery and was shown to be one of the most powerful tools for hit identification. However, an HTS campaign “per se” is typically not sufficient to support the selection and prioritization of the chemical matter identified. Therefore, focused follow-up activities become crucial for choosing the most promising hits.

In this interactive lunch & learn session, Dr. Iolanda Micco, Head of Discovery at Axxam will introduce their  “HIT QUALIFICATION” strategy as an effective and fundamental tool to unlock the true value of hits derived from HTS campaigns. She will talk about how biology and chemistry expertise can melt together to ensure a comprehensive validation, optimization, and prioritization of the best-suited molecules, thus enhancing the probability of downstream success and maximizing the value of this early yet impactful phase of drug discovery research.  
About the speaker: Dr. Iolanda Micco is currently Head of Discovery Chemistry at Axxam in Italy, a leading provider of high-quality services for the identification of small molecules in drug discovery research. With PhD in medical chemistry from the University of Siena, Italy, she boasts more than 15 years of international experience in pivotal management and strategic roles.